LifeMD, Inc. (NASDAQ:LFMDP – Get Free Report) was the recipient of a significant increase in short interest during the month of March. As of March 31st, there was short interest totalling 2,500 shares, an increase of 525.0% from the March 15th total of 400 shares. Based on an average trading volume of 3,600 shares, the days-to-cover ratio is presently 0.7 days.
LifeMD Stock Performance
Shares of LFMDP traded up $0.26 during midday trading on Monday, reaching $23.40. The stock had a trading volume of 58,705 shares, compared to its average volume of 3,479. The firm has a 50 day simple moving average of $23.30 and a 200-day simple moving average of $22.68. LifeMD has a one year low of $20.25 and a one year high of $27.44.
LifeMD Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Friday, April 4th will be issued a dividend of $0.5547 per share. This represents a $2.22 dividend on an annualized basis and a yield of 9.48%. The ex-dividend date of this dividend is Friday, April 4th.
About LifeMD
LifeMD, Inc operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies.
Featured Stories
- Five stocks we like better than LifeMD
- What does consumer price index measure?
- Why NVIDIA Stock Could Soar Despite Wall Street Downgrades
- What Are Growth Stocks and Investing in Them
- Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or Hold
- What Are Dividend Champions? How to Invest in the Champions
- 3 Hot New IPOs Defying the 2025 Market Slump
Receive News & Ratings for LifeMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeMD and related companies with MarketBeat.com's FREE daily email newsletter.
